Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that at its EGM held on December 30, 2021, shareholders approved the appointment of Liu Yanbin and Sun Yunxia as non-independent directors, Cao Deying and Wang Xiabngjun as independent directors and Gao Shuxuan and Wang Jinliang as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.03 CNY | +0.10% |
|
-6.87% | -22.91% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.91% | 1.27B | |
+2.08% | 95.18B | |
-0.13% | 37.55B | |
-10.62% | 33.75B | |
+77.76% | 28.2B | |
-15.00% | 15.63B | |
-2.90% | 13.63B | |
-12.76% | 11.5B | |
+181.73% | 10.81B | |
-53.92% | 9.23B |
- Stock Market
- Equities
- 300255 Stock
- News Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Announces Board Appointments